Genetic
ICM-203
ICM-203 is a genetic therapy with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Enrolling by invitation1
Not yet recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 12 (100.0%)
Trials by Status
enrolling_by_invitation133%
not_yet_recruiting133%
active_not_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
enrolling_by_invitation
A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo
NCT05752032
not_yet_recruitingphase_1
A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.
NCT05454566
active_not_recruitingphase_1
A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis
NCT04875754
Clinical Trials (3)
Showing 3 of 3 trials
NCT05752032
A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo
NCT05454566Phase 1
A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.
NCT04875754Phase 1
A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis
All 3 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 3